HomeMarket NewsThe Ups and Downs of Biolase Stock: A Financial Review of Q4...

The Ups and Downs of Biolase Stock: A Financial Review of Q4 2023 Earnings

Actionable Trade Ideas

always free

BIOL stock - Biolase Stock Earnings for Q4 2023

Source: iQoncept / Shutterstock

Biolase (NASDAQ:BIOL) recently unveiled its performance for the final quarter of 2023.

  • The earnings per share stood at -$1.76, surpassing the expected EPS of -$2.55.
  • However, the company recorded revenue of $13.49 million, falling slightly short of the anticipated $13.55 million.

InvestorPlace Earnings, powered by TradeSmith data, succinctly presents crucial details from quarterly earnings reports. The analysis covers earnings per share, revenue figures, and the company’s alignment with analyst projections. These reports are produced promptly and without direct human input, ensuring swift dissemination of financial insights. Any discrepancies or issues can be reported to [email protected].


Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/biol-stock-earnings-biolase-for-q4-of-2023/.

Β©2024 InvestorPlace Media, LLC

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.